# Sanara MedTech Inc. (SMTI)

Source: https://www.quantisnow.com/company/SMTI
Generated: 2026-10-30T21:01:51.011Z

- Ticker: SMTI
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Industrial Specialties
- SEC CIK: 0000714256
- Website: sanaramedtech.com

## About

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical Activated Collagen Adjuvant powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. It also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers; and PULSAR II Advanced Wound Irrigation System, a portable and no touch hydro-mechanical debridement system that removes bacteria and necrotic tissue without disrupting healthy tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

## Latest SMTI news and filings

- 2026-10-29 20:15 UTC [SEC Form 8-K] [SEC Form 8-K filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-sanara-medtech-inc-6763702)
- 2026-10-16 13:24 UTC [SEC Form 425] [SEC Form 425 filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-sanara-medtech-inc-6748859)
- 2026-10-16 13:20 UTC [SEC Form 8-K] [SEC Form 8-K filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-sanara-medtech-inc-6748856)
- 2026-09-30 23:48 UTC [SEC Form 8-K] [Sanara MedTech Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events](https://www.quantisnow.com/insight/sanara-medtech-inc-filed-sec-form-8-k-submission-of-matters-6731198)
- 2026-09-16 20:02 UTC [SEC Form 4] [Chief Executive Officer Yon Seth D covered exercise/tax liability with 3,661 shares, decreasing direct ownership by 3% to 105,885 units (SEC Form 4) (tax withholding)](https://www.quantisnow.com/insight/chief-executive-officer-yon-seth-d-covered-exercisetax-liability-with-6717418)
- 2026-09-04 20:08 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-sanara-medtech-inc-6706778)
- 2026-08-20 20:05 UTC [SEC Form 425] [SEC Form 425 filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-sanara-medtech-inc-6689988)
- 2026-08-11 21:08 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-sanara-medtech-inc-6676405)
- 2026-08-11 20:11 UTC [SEC Form 425] [SEC Form 425 filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-sanara-medtech-inc-6675850)
- 2026-08-11 20:10 UTC [SEC Form 8-K] [Sanara MedTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition](https://www.quantisnow.com/insight/sanara-medtech-inc-filed-sec-form-8-k-results-of-operations-6675831)
- 2026-08-11 20:10 UTC [Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)](https://www.quantisnow.com/insight/sanara-medtech-inc-reports-second-quarter-2026-financial-results-unaudited-6675791)
- 2026-08-11 20:06 UTC [SEC Form 425] [SEC Form 425 filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-sanara-medtech-inc-6675736)
- 2026-08-11 20:05 UTC [SEC Form 8-K] [Amendment: Sanara MedTech Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-sanara-medtech-inc-filed-sec-form-8-k-entry-into-6675687)
- 2026-07-30 17:51 UTC [SEC Form 425] [SEC Form 425 filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-sanara-medtech-inc-6655750)
- 2026-07-30 17:53 UTC [SEC Form 425] [SEC Form 425 filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-sanara-medtech-inc-6655749)
- 2026-07-30 17:54 UTC [SEC Form 425] [SEC Form 425 filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-sanara-medtech-inc-6655746)
- 2026-07-30 17:49 UTC [SEC Form 425] [SEC Form 425 filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-sanara-medtech-inc-6655742)
- 2026-07-30 17:48 UTC [SEC Form 425] [SEC Form 425 filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-sanara-medtech-inc-6655741)
- 2026-07-30 17:38 UTC [SEC Form 425] [SEC Form 425 filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-sanara-medtech-inc-6655737)
- 2026-07-30 17:40 UTC [SEC Form 425] [SEC Form 425 filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-sanara-medtech-inc-6655735)
- 2026-07-30 11:53 UTC [Analyst Downgrade] [Sanara MedTech downgraded by H.C. Wainwright with a new price target](https://www.quantisnow.com/insight/sanara-medtech-downgraded-by-hc-wainwright-with-a-new-price-6655083)
- 2026-07-29 20:24 UTC [SEC Form 425] [SEC Form 425 filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-sanara-medtech-inc-6653964)
- 2026-07-29 20:21 UTC [SEC Form 8-K] [Sanara MedTech Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sanara-medtech-inc-filed-sec-form-8-k-entry-into-a-6653942)
- 2026-07-29 20:07 UTC [Earnings Date] [MIMEDX Announces Second Quarter 2026 Operating & Financial Results](https://www.quantisnow.com/insight/mimedx-announces-second-quarter-2026-operating-financial-results-6653631)
- 2026-07-29 20:01 UTC [Earnings Date] [MIMEDX to Acquire Sanara MedTech](https://www.quantisnow.com/insight/mimedx-to-acquire-sanara-medtech-6653441)
- 2026-06-09 20:15 UTC [SEC Form 8-K] [SEC Form 8-K filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-sanara-medtech-inc-6595345)
- 2026-06-06 00:31 UTC [SEC Form 4] [Director Tanzberger Eric D was granted 5,308 shares, increasing direct ownership by 30% to 22,966 units (SEC Form 4)](https://www.quantisnow.com/insight/director-tanzberger-eric-d-was-granted-5308-shares-increasing-direct-6592273)
- 2026-06-06 00:31 UTC [SEC Form 4] [Director Major Eric D was granted 4,846 shares, increasing direct ownership by 52% to 14,232 units (SEC Form 4)](https://www.quantisnow.com/insight/director-major-eric-d-was-granted-4846-shares-increasing-direct-6592272)
- 2026-06-06 00:31 UTC [SEC Form 4] [Director Ortwein Sara N was granted 4,616 shares, increasing direct ownership by 22% to 25,415 units (SEC Form 4)](https://www.quantisnow.com/insight/director-ortwein-sara-n-was-granted-4616-shares-increasing-direct-6592271)
- 2026-06-06 00:31 UTC [SEC Form 4] [Director Nixon Ronald T was granted 4,154 shares, increasing direct ownership by 6% to 68,196 units (SEC Form 4)](https://www.quantisnow.com/insight/director-nixon-ronald-t-was-granted-4154-shares-increasing-direct-6592270)
- 2026-06-06 00:31 UTC [SEC Form 4] [Director Desutter Robert Andrew was granted 5,539 shares, increasing direct ownership by 24% to 28,740 units (SEC Form 4)](https://www.quantisnow.com/insight/director-desutter-robert-andrew-was-granted-5539-shares-increasing-direct-6592269)
- 2026-06-06 00:31 UTC [SEC Form 4] [Director Salamone Ann Beal was granted 4,154 shares, increasing direct ownership by 18% to 26,858 units (SEC Form 4)](https://www.quantisnow.com/insight/director-salamone-ann-beal-was-granted-4154-shares-increasing-direct-6592268)
- 2026-06-06 00:31 UTC [SEC Form 4] [Director Mack Roszell Iii was granted 5,308 shares, increasing direct ownership by 32% to 21,842 units (SEC Form 4)](https://www.quantisnow.com/insight/director-mack-roszell-iii-was-granted-5308-shares-increasing-direct-6592267)
- 2026-06-06 00:31 UTC [SEC Form 4] [Director Myers Keith G was granted 4,385 shares, increasing direct ownership by 89% to 9,325 units (SEC Form 4)](https://www.quantisnow.com/insight/director-myers-keith-g-was-granted-4385-shares-increasing-direct-6592266)
- 2026-06-04 20:15 UTC [SEC Form 8-K] [Sanara MedTech Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement](https://www.quantisnow.com/insight/sanara-medtech-inc-filed-sec-form-8-k-termination-of-a-6589489)
- 2026-05-18 20:02 UTC [SEC Form 4] [Chief Executive Officer Yon Seth D covered exercise/tax liability with 3,852 shares, decreasing direct ownership by 3% to 109,546 units (SEC Form 4) (for tax liability)](https://www.quantisnow.com/insight/chief-executive-officer-yon-seth-d-covered-exercisetax-liability-with-6560010)
- 2026-05-12 20:03 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Sanara MedTech Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-sanara-medtech-inc-6547789)
- 2026-05-11 21:21 UTC [SEC Form 8-K] [Sanara MedTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sanara-medtech-inc-filed-sec-form-8-k-results-of-operations-6545885)
- 2026-05-11 20:50 UTC [Earnings Date] [Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)](https://www.quantisnow.com/insight/sanara-medtech-inc-reports-first-quarter-2026-financial-results-unaudited-6545601)
- 2026-05-05 20:05 UTC [SEC Form 4] [Amendment: Controller Mackey Ashley M was granted 2,804 shares, increasing direct ownership by 130% to 4,967 units (SEC Form 4)](https://www.quantisnow.com/insight/amendment-controller-mackey-ashley-m-was-granted-2804-shares-increasing-6531966)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SMTI
- RSS and alerts for SMTI: https://www.quantisnow.com/docs/rss-feeds.md